Indaptus Therapeutics News

Indaptus Therapeutics | EFFECT: Others

Sep 23 18:03

Indaptus Therapeutics | 424B5: Prospectus

Aug 8 05:32

Indaptus Therapeutics | 424B5: Prospectus

Aug 7 05:28

Indaptus Therapeutics | 424B5: Prospectus

Mar 14 05:05

Indaptus Therapeutics | 424B5: Prospectus

Mar 28, 2023 05:10

Indaptus Therapeutics | EFFECT: Others

Jan 3, 2023 13:15

Indaptus Therapeutics | 424B3: Prospectus

Dec 31, 2022 05:36

Indaptus Therapeutics | EFFECT: Others

Sep 12, 2022 12:15

Indaptus Therapeutics | EFFECT: Others

Mar 24, 2022 12:15

Indaptus Therapeutics | EFFECT: Others

Dec 2, 2021 13:15

Indaptus Therapeutics | EFFECT: Others

Sep 30, 2021 12:15

Indaptus Therapeutics | 424B3: Prospectus

Sep 30, 2021 01:20

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 30, 2021 05:17

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 24, 2021 04:33

Indaptus Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jul 24, 2021 04:11

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 17, 2021 05:12